Each 5 ml contains

  • Cyproheptadine anhydrous 2.0mg
  • Tricholine Citrate 2.75mg
  • Sorbitol 3.57mg
  • Total content is 200ml per bottle


HOGINZ Liquid contains Cyprohetadine,Tricholine citrate and Sorbitol. Cyproheptadine (Cp), an antihistamine serotonin antagonist drug with appetite-stimulating activity, was given to children with growth hormone (GH) deficiency to test the hypothesis that increased weight gain would enhance the effect of GH on linear growth. Cyproheptadine hydrochloride is a serotonin and histamine antagonist use in children for allergic rhinitis, allergic conjunctivitis, urticaria, dermatographism and mild angioedema. Unexplained weight gain has been observed in patients taking Cyproheptadine. Cyproheptadine for appetite can be highly effective in patients who have a reduced desire to eat, or need to gain weight. This drug is an effective appetite stimulant in children with asthma, failure to thrive, short stature, and anorexia nervosa.

Tricholine Citrate is a hepato-protective agent .Tricholine Citrate increases appetite and spares methionine for growth.Tricholine citrate exerts lipotropic action in the hepatic cells. Choline converts deposited fats into lecithin and other similar phospholipids. Lecithin is a major component of high density lipoprotein (HDL) that mobilizes cell membrane cholesterol and promotes hepatic degeneration. In cirrhosis and fatty liver, an increased level of plasma phospholipids can be observed after Tricholine citrate administration


HOGINZ Liquid stimulates appetite, provides effective hepato-protective action, ensures weight gain, and enhances protein synthesis. It is indicated in hepatobiliary disorders associated with anorexia resulting in weight loss.


As directed by physician


HOGINZ Liquid should not be administered in the following cases:

  • It should not be prescribed to individuals allergic to any other component present in this formula.
  • HOGINZ Liquid is contraindicated in patients of Bulimia Nervosa (where patient takes excess food).
  • HOGINZ Liquid is not recommended in patients with angle-closure glaucoma; stenosing peptic ulcer; symptomatic prostatic hypertrophy; bladder neck obstruction; pyloroduodenal obstruction; elderly, debilitated patients.


HOGINZ Liquid may interfere with skin allergy tests,one need to stop taking it for a few days before the tests.

Use HOGINZ LIquid with caution in the ELDERLY; they may be more sensitive to its effects, especially dizziness, drowsiness, and low blood pressure.

HOGINZ LIquid should not be used in NEWBORNS and PREMATURE INFANTS; safety and effectiveness in these children have not been confirmed.

HOGINZ LIquid may cause sunburned more easily. Avoid the sun, sunlamps, or tanning booths or use sunscreen when an individual is outside for more than a short time.

Cyproheptadine has an atropine-like action and, therefore, should be used with caution in patients with history of bronchial asthma,Increased intraocular pressure, Hyperthyroidism, Cardiovascular disease, Hypertension.


Adverse reactions associated with HOGINZ Liquid can be attributed to cyproheptadine. These may include sedation (often transient), dizziness, disturbed coordination, onfusion, restlessness, rash, urticaria, blurred vision, diplopia, vertigo, tinnitus, hypotension, palpitation, tachycardia, dryness of mouth, anorexia, diarrhea, constipation ,urinary retention, dryness of nose and throat and thickening of bronchial secretions.


HOGINZ Liquid has positive evidence of risk to a breastfed infant or to breast milk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant e.g. if the drug is needed in a life threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective.


HOGINZ Liquid is available as syrup. The total content in each bottle is 200 ml.


The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment. Please note it is dangerous to take any medication without doctor’s prescription or professional advice from a registered health practitioner. Always follow the instructions of physician / doctor / registered medical practitioner before using any medicine. Do not exceed the recommended dosage. Keep all medicines away from your children. Store as recommended. Please consult your health care provider, before making any healthcare decisions or for guidance about a specific medical condition. The allopathic medicine as per the law in India must be sold by retail pharmacies holding valid trading drug license only.